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Abstract
Background: Many preventable diseases such as ischemic heart diseases and breast cancer prevail
at a large scale in the general population. Computerized decision support systems are one of the
solutions for improving the quality of prevention strategies.
Methods: The system called EsPeR (Personalised Estimate of Risks) combines calculation of several
risks with computerisation of guidelines (cardiovascular prevention, screening for breast cancer,
colorectal cancer, uterine cervix cancer, and prostate cancer, diagnosis of depression and suicide
risk). We present a qualitative evaluation of its ergonomics, as well as it's understanding and
acceptance by a group of general practitioners. We organised four focus groups each including 6–
11 general practitioners. Physicians worked on several structured clinical scenari os with the help
of EsPeR, and three senior investigators leaded structured discussion sessions.
Results: The initial sessions identified several ergonomic flaws of the system that were easily
corrected. Both clinical scenarios and discussion sessions identified several problems related to the
insufficient comprehension (expression of risks, definition of familial history of disease), and
difficulty for the physicians to accept some of the recommendations.
Conclusion: Educational, socio-professional and organisational components (i.e. time constraints
for training and use of the EsPeR system during consultation) as well as acceptance of evidence-
based decision-making should be taken into account before launching computerised decision
support systems, or their application in randomised trials.
Background
In France, a considerable number of deaths are due to pre-
ventable diseases. Ischemic heart diseases and cerebrovas-
cular diseases still account for more than 80,000
premature deaths and breast cancer, more than 10,000
deaths. The control of the main cardiovascular risk factors,
such as hypertension, remains poor, both because of lack
of awareness and insufficient blood pressure control [1].
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The objectives of breast cancer screening (mammography
every 2 years in women aged between 50 and 69 years rec-
ommended in French guidelines) are not completely
attained either [2].
In France, the promotion of prevention strategies in the
ambulatory setting remains a national challenge. Several
initiatives have been undertaken by Public Health author-
ities and by Health Insurance National Office, to prompt
general practitioners to modify their prevention practices
and improve their adherence to national guidelines. The
development of the EsPeR system (Personalised Estimate of
Risks) is one of these actions. It relies on three hypotheses:
1. for a given individual, an accurate estimation of his
(her) health risks allows a more pertinent choice of pre-
vention interventions
2. presentation of a patient-customized clinical guideline,
will promote its implementation.
3. the combination of risk estimations and patient-spe-
cific guidelines embedded in a computerised decision aid
can promote physician application of guideline recom-
mendations during consultations and stimulate the com-
munication with the patient.
The objective of this paper is to describe EsPeR, a compu-
terised decision support system designed to help preven-
tion practices by use of risk estimates and guidelines and
to present a pilot qualitative evaluation of its ergonomics,
understanding and acceptance by general practitioners.
Methods
Design of EsPeR
The EsPeR system is designed for health professionals and
it is freely accessible on the Internet, after a simple identi-
fication process. An interactive decision support system
allows an estimation of risks and a presentation of clinical
guidelines. A non-interactive part describes the scientific
rationale and background of the system (the documenta-
tion part) and provides its sources of medical and epide-
miological knowledge (the library part). The following
functional description focuses on the decision support
system.
Functional description
The decision support system on the EsPeR  website
includes four primary functions:
1. Presentation of the 10 highest risks of avoidable causes
of death according to demographic characteristics (age,
sex and region of residence).
2. Estimation of specific risks, using published risk predic-
tion models.
3. Individualized presentation of French guidelines on
cardiovascular risk management and cancer screening
4. Printable summary of prevention messages for physi-
cians and patients.
Highest risks of death
For a specific patient, the user is asked to enter the system
via a screen that presents the 10 highest risks of avoidable
causes of death according to demographic characteristics
(age, sex and region of residence) (see figure 1). The total
10-year mortality risk is displayed along with the absolute
risk and the relative part of risk for each cause. These prob-
abilities have been computed from 1) the French national
statistics on the causes of deaths (along with available
explicative variables (age, sex and region of residence) and
2) the French population data given by 1990 national cen-
sus and intermediate estimates by INSEE (the French
national Institute of Statistics and Economics). The prob-
ability of death from one cause, at a given age is estimated
thanks to the method used by INSEE, based on a the use
of fictitious cohort, which allows to estimate prospective
probabilities from the transformation of transversal
observational data [3]. The aim of this part is to suggest a
hierarchy of preventable risks that should be adjusted
according to the patient specific risk factors (e.g.  con-
sumption of tobacco and alcohol, blood pressure level,
etc.).
Specific risks and individualized guidelines
After this first screen the physician can choose the specific
risks he(she) wants to further estimate and consider for
prevention in his(her) patient (cardiovascular risk, alco-
hol abuse screening, breast cancer, colorectal cancer, uter-
ine cervix and prostate cancer screening, depression and
suicide risk). A data input form is dynamically created
with relevant clinical and biological items, once the phy-
sician has selected the risks (Figure 2). For breast cancer
and cardiovascular disease, the form is integrated with a
module which allows to create a family tree, enter disease
history for each person in the pedigree and estimate famil-
ial risk of the patient [4] (Figure 3). The validation of the
form provides a risk estimate for each selected risk, and a
presentation of guidelines.
The method of implementation of guidelines has been
previously described [5]. It relies on a generic guideline
representation model derived from the GLIF 2 (Guideline
Interchange Format) model [6], and the use of XML as a
language of representation for any specific guideline,
according to a specific DTD (document type definition) ofBMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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this model. An inference engine implements the guideline
model and executes any specific guideline represented in
XML.
All original guidelines have been analysed to specify a
decision algorithm, represented in XML language, and a
list of elementary messages (e.i. extracts of guideline for a
given patient profile). Two physicians experienced in
medical informatics performed these analysis and specifi-
cations. For a given patient, the presentation of guideline
consists in 1) the list of variables (i.e. the patient's charac-
teristics) used in the decision algorithm, and 2) the suc-
cessive elementary recommendations related to his(her)
characteristics.
Knowledge base
All knowledge used in the system has been selected on the
basis of extensive validation (according to evidence-based
medicine methodology). Cardiovascular risks and breast
cancer risk are computed thanks to published risk predic-
tion models [7,8]. We considered the Framingham mod-
els as sufficiently validated for cardiovascular risk
stratification in various cohorts, including French ones [9-
11]. Since the Gail model for breast cancer has never been
tested on any French data, we chose to only present an
estimate of relative risk. Provided guidelines have been
selected from those published by the French National
Agency for Health Evaluation (ANAES) for:
• Diagnosis and management of hypertension, hyperlipi-
demia, and type 2 diabetes
• Screening for breast cancer, colorectal cancer, cervical
cancer, and prostate cancer
• Diagnosis of depression and suicide risk
Presentation of the ten first causes of mortality in a women aged 55 years, in the EsPeR system Figure 1
Presentation of the ten first causes of mortality in a women aged 55 years, in the EsPeR systemBMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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• Diagnosis and management of alcohol abuse.
Printable summary
Finally, a printable summary of all risk estimates and
guidelines is made accessible for both physician and
patient, with words and format adapted to each.
Technical architecture
The EsPeR system is based on a 3-tier client-server architec-
ture. The concepts used by the decision support modules
(patient data, risks estimates) are implemented in JAVA
classes; these classes encapsulate relational databases with
SQL queries and generate with the results HTML pages by
using Active Server Pages technology.
Qualitative evaluation
Following published recommendations [12], we designed
a pilot qualitative study to evaluate the ergonomics,
understanding and acceptance of the interactive decision
support system of EsPeR  by general practitioners. The
main objective of this preliminary evaluation in labora-
tory was to appreciate how general practitioners could use
and react to EsPeR and to go in depth with them into their
reactions and beliefs. A secondary objective of this study
was to prepare a larger qualitative study to be organised in
ambulatory practice, with use of EsPeR  during
consultation.
Study design
The study was performed in two sessions, each consisting
in two focus groups. The first session was organised in Jan-
uary 2002 with the version 1 of the system and the second
one in October 2002, with the version 2, improved
according to several results of the first session. The differ-
ences between the first version and the second one con-
cern the number of provided guidelines and the global
Data form after selection of breast cancer risk Figure 2
Data form after selection of breast cancer riskBMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
Page 5 of 11
(page number not for citation purposes)
ergonomics and navigation within the site. All focus
groups were animated by three investigators (GC, IC and
TD for the first and second ones, GC, IC and LL for the
third and fourth ones)
Each focus group was divided into four phases: 1) a struc-
tured discussion to evaluate skills and culture on
prevention (at the beginning of the session) 2) a presenta-
tion of the project and short training to EsPeR (1 hour), 3)
an individual work on 6 to 12 structured clinical scenarios
with or without EsPeR (2 to 4 hours) and 4) a structured
discussion to draw a consensus synthesis on the evalua-
tion of EsPeR (at the end of the session) (1 to 2 hours).
The same investigator (GC) conducted discussion during
phases 1 and 4 in all groups, according to outlines pre-
sented in Table 1, while the others (IC and TD for the 1st
session in January and IC and LL for the 2nd session in
October) took notes of the discussion. The later were
asked to transcribe original comments of physicians as
faithfully as possible, rather than their own interpreta-
tions. Both topics of discussion (prevention and synthesis
of evaluation) were also addressed thanks to a structured
individual questionnaire filled out by physicians before
the corresponding discussion.
During the second phase, the three investigators observed
the physicians' behaviour in using the system. They col-
lected physicians' remarks, difficulties and suggestions,
along with their personal comments or opinion on these
reactions. Structured clinical scenarios were formulated
according to a priori hypotheses on physician's practices or
beliefs, which could be in contradiction with the scientific
content of EsPeR. For example, as current French guideline
recommend systematic mammography screening of
breast cancers in women aged 50 to 70 years, we depicted
Presentation of the pedigree in the familial history module Figure 3
Presentation of the pedigree in the familial history moduleBMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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a scenario of a 43 aged women with average personal risk
of breast cancer according to the Gail model (particularly,
with one history of breast cancer in her mother, diagnosed
at the age of 70). Physicians were asked to answer to each
scenario on a structured form, about what would be their
estimates of health risks and prevention strategies,
whether concordant or not with EsPeR, used as decision
aid.
Recruitment of general practitioners
Physicians were recruited differently for both sessions. For
the January session, we requested volunteers in two differ-
ent professional groups by the intermediate of the execu-
tive manager of each group (the National French
Federation of Mutuality, which manages non for profit
health centres with full-time of part time salaried GPs, and
the National College of Teaching GPs). For the October
session, we recruited volunteers by a mail shot to physi-
cians who practice in two administrative departments of
France (n = 437 in Indre et Loire, n = 135 in Seine et
Marne) and who already participated in a prevention pro-
gram organized by the CANAM (Health Insurance
National Office for non salaried workers). Volunteers
were asked to have minimal computer and Internet skills.
In each focus group, the participants were not supposed to
know each other and had no working contacts with the
investigators before the sessions. All GPs were paid for
their participation in the study.
Data collection and analysis
Demographic and professional characteristics of partici-
pants were collected by a questionnaire mailed to each
participant before the session.
Evaluation data were collected:
1. During the discussion phases: from discussion notes
collected by two investigators
2. During individual work on clinical scenarios: from
standardized structured answer form filled out by each
physician for all scenarios, with open commentaries and
observation notes from the three investigators
3. Using two structured questionnaires evaluating the
degree of knowledge (beginning of the session) and the
satisfaction of physicians with EsPeR (end of the session).
Observations and discussion notes collected by the differ-
ent investigators were all pooled together, with indication
of the origin of each item (original comments by physi-
cians or interpretation by investigators). They were sum-
marized by one investigator (IC) and validated by two
others (by GC and TD in January then by GC and LL in
October). This qualitative verbatim of the focus group was
further classified into:
• Ergonomics of the system (navigation, speed,
intuitiveness)
• Understanding of contents
• Acceptance of advices (barriers and facilitators to put
guidelines into practice).
We also checked the consistency of this verbatim with
answers to questionnaires and we tried to infer from this
Table 1: Outlines for structured discussion in focus groups
Discussion on prevention Consensus synthesis
• Physician point of view • Ergonomics and adoption of the computer decision support system (by 
main functionalities)
What is prevention?
Knowledge on risk (vocabulary, interpretation) • Patient medical record (PMR)
Knowledge on guidelines Unique/multiple forms
Current use of guidelines Archives
Part of prevention in their practice Interoperability with personal practice PMR
• Patient point of view (as perceived by physicians) • Presentation of risks
Expectations for prevention Were they puzzled by risk estimates?
Attitudes and adherence to the process of risk control Perceived utility of risk estimates for the care of individual patients
• Expectations of physicians for computer decision support systems: • Presentation of guidelines
Perceived appropriateness of advices in GPs field practice
For medical decision making
To be usable while facing the patient • Printable synthesis for patient
For communication with patients Usability for communication with patients
For continuous medical educationBMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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verbatim some pragmatic interpretation potentially lead-
ing to concrete improvement of the EsPeR system.
Finally, we analysed the answers to each individual clini-
cal scenario as concordant or discordant with the answers
recommended in EsPeR. We expressed this concordance in
terms of "acceptance" ("not acceptable": no concordance
with the recommendation of EsPeR  and negative com-
ments from physicians; "intermediate": no concordance
but no negative comments or concordance but negative
comments; "acceptable": concordance with the
recommendation of EsPeR and positive comments). We
tried to explain this acceptance in the light of the verbatim
of the focus group.
Results
Participants characteristics
The four focus groups were performed respectively with a
total of 36 participants (11 and 11 in January session, 8
and 6 in October session). Mean age was 48 years, 89%
were male and 80% used electronic medical record soft-
ware. The four groups were different in terms of profes-
sional setting and use of informatics (Table 2).
Problems of ergonomics
Several problems of ergonomics were clearly identified
with the two first groups in January (both through obser-
vation by investigators and reports by physicians). These
problems concerned:
• Navigation in the family tree module
• Navigation between data forms and results (risk and
guidelines)
• Absence of archive of medical record and absence of an
export function to avoid duplicate data entry (in EsPeR
and in personal EMR software)
Some solutions to these problems were developed for the
version 2 and GPs of the October sessions found the ergo-
nomics and navigation correct, easy to use and fast
enough (see Table 3). Physicians needed 15 to 20 minutes
to work on one clinical scenario with EsPeR.
Problems of understanding
The physicians' understanding of risks was highly varia-
ble. Several of them were not familiar with a quantitative
estimate of risk. They did not know how to apply the
absolute risk provided in EsPeR and asked for explana-
tions. Few participants asserted being more confident in
their own risk estimate. Few GPs did not know clinical
practice guidelines. Most had heard about them but did
not refer to them, and few both read and used them rou-
tinely (Table 3).
Acceptance of EsPeR content
The acceptance of the guideline messages was evaluated
from GPs answers to clinical scenarios (adherence or no
adherence to the messages), from their reactions observed
during individual work and from the comments reported
in discussion notes during open group discussion (Table
3). The cardiovascular guidelines were in general better
Table 2: Characteristics of participants (figures are numbers)
January session October session
Group A (n = 11) Group B (n = 11) Group A (n = 8) Group B (n = 6)
Age, median (IQR) 46 (11) 51 (10) 42.5 (11.5) 51 (10)
Sex (number of males) 8 11 7 6
Practice setting
H e a l t h  c e n t r e 5100
Teaching activity 3800
Ambulatory (urban) - - 6 4
Ambulatory (semi-rural) - - 2 2
Use of computer during 
consultation
61 08 6
Use of an electronic 
medical record (EMR)
61 08 5
Use of EMR during 
consultation
41 07 5
Use of decision support 
systems for diagnosis
2411
Use of decision support 
systems for prescription
2985BMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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Table 3: Extracts of discussion notes and written open comments by participating physicians
Discussion notes on prevention
January 2002: October 2002:
Prevention is:
"individual prevention or population prevention?"
"to inform the patient"
"to educate the patient for health: nutrition, etc."
"cancer prevention consists in regular and systematic exam, more 
specifically according to particular risks of patients"
"a lot of time !" "the activity of prevention is guided more by a the 
reasons of consultations or the circumstances than by any structured 
prevention plan."
Demand of patients:
"there is an harmful role of the medias: sometime, patients are informed 
before we are"
"patients would accept messages of prevention if we had more time with 
them"
Guidelines:
"there are too many of them" "we lack time to read them"
"we can agree with them but not use them"
"general practitioners are not involved enough in their development" 
"guidelines avoid to do bibliography and the ANAES is independent from 
Health Insurance institutions"
Prevention is:
"Prevention is included in the time of regular consultation, according to 
its context"
"to use appropriate means to avoid accidents and diseases"
"a specific consultation for prevention would be twice longer than 
regular consultation"
"
Guidelines:
"ANAES guidelines are more acceptable for us when we have the 
opportunity to work on them in our continuous medical education 
group"
"we trust the ANAES guidelines more than experts opinions"
"there are a strong pressure by the media on patients concerning PSA 
screening"
Written open comments on clinical scenario answer forms
January 2002: October 2002:
"the keyboarding is too long in the family history module"
"EsPeR does not take into account the treatment of risk factors"
"Two myocardial infarctions and one stroke in the family (uncles and 
aunts) do not constitute a familial risk"
"there is no estimated familial risk despite her mother had breast 
cancer"
"I will prescribe a mammography, even though EsPeR tells me it is not 
recommended."
"Don't forget that we care of a patient who does not care about his(her) 
probability or about the cost of his(her) screening test"
"EsPeR helps to be aware of intensity of risks",
"EsPeR helps to balance risk of cardiovascular diseases and risk of 
cancer",
"I thought I knew the guidelines... finally: I don't",
"I did not find any answer with EsPeR"
"We cannot refuse a mammography screening to a 43 years aged 
women, even though screening is recommended at 50 years of age."
"There is a strong incentive from laboratories to use PSA for systematic 
prostate cancer screening" * (it is not recommended by guideline in 
EsPeR)
"I am questioned in my idea on the pertinence of screening"
Discussion notes on evaluation synthesis
January 2002: October 2002:
"EsPeR is not ready for use in consultation"
"This tool is not appropriate for daily practice"
"EsPeR is easy to use, but difficult to integrate in one consultation"
"EsPeR allow to learn"
"Criteria used to define risk are too strict. In practice, we use fuzzy 
criteria"
"We trust our clinical experience to estimate risks" "the statistical truth 
is not the clinical truth"
"I need to adapt guideline to my personal practice"
"cognitive interest of the individualisation of guidelines brought at the 
moment of decision"
"I was able to integrate the concepts of risk only when I started working 
with EsPeR.
"I learned something today...I have practiced prevention for 23 years, 
only based on my common sense"
"The presentation of mortality data provides an interesting tool to 
communicate with the patient"
"We need a framework to interpret risks or some labels; we do not 
know how to relate cardiovascular risk with mortality risk"
"more warnings and more active alerts are needed from the estimations 
of risks"
"highlight individual messages better in guideline messages"
"we often overestimate familial risks"BMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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accepted than guidelines on cancer screening. Several rec-
ommendations given by EsPeR concerning cancers screen-
ing were perceived as inappropriate because of patients'
demands and social or organizational pressures.
Overall, physicians perceived the system as useful. Few
participants would have liked to be guided more directly
to select the risks that should be considered in priority for
prevention for a given patient.
Table 4 presents examples of the acceptance of some rec-
ommendations of EsPeR, for different clinical situations
addressed in scenarios, along with plausible explanations
and solutions inferred from discussion notes and from
physicians' comments.
Discussion
The present paper describes a computerised system
devoted to the prevention of avoidable morbidity, based
on risk assessment and valid recommendations. The main
objective of EsPeR is to put in perspective the different
health risks for one individual and to present guideline
messages appropriate for this individual. The hierarchy of
risks currently relies on the presentation of French mortal-
ity data and is therefore poorly "individualized", taking
into account age, sex and region of residence. A more
accurate estimate of several risks is possible thanks to
specific models such as the Framingham model. However,
these models have been demonstrated as being ade-
quately discriminent but poorly calibrated in French pop-
ulation [10,13]. Other models have been recently
published thanks to the SCORE project and are recom-
mended by the Third Joint Task Force of European Socie-
ties on Cardiovascular prevention [14,15]. We intend to
Table 4: Degree of acceptance of guideline messages, possible interpretation and solutions
Examples of clinical scenarios 
(and corresponding guideline 
message)
Acceptance of EsPeR advice# Characterization of the 
problem of acceptance
Possible solution
Tobacco smoking (only the last 
year consumption is taken into 
account in EsPeR)
Intermediate Lack of knowledge (cardiovascular 
risk returns to baseline after 
smoking cessation)
More explicit reasoning and 
detailed explanations
Familial cardiovascular risk of a 60-
year old man with 2 brothers who 
had myocardial infarction at more 
than 70 years of age... (no familial 
risk according to the definition 
used in the guideline)
Not acceptable Over estimation of familial risk. 
Knowledge and evidence disagree 
with common sense and inherited 
cultural belief
More explanation and information 
on evidence
Absence of familial risk of breast 
cancer in a woman whose mother 
had a breast cancer at 60 and had 
no other family member having 
had a cancer
Intermediate Knowledge and evidence disagree 
with common sense and inherited 
cultural belief
More explanation and information 
on evidence
Breast cancer screening in a 43-
year old women at average risk 
(mammography not recommended 
as systematic screening, genetic 
screening only if high familial risk)
Not acceptable Over-estimation of familial risk. 
High pressure (anxiety) of patients 
for screening without knowledge 
on benefit and risk of screening
More accurate information 
targeted on both the physician and 
the patient
Colorectal cancer screening by 
colonoscopy in a 60-year old man 
whose father is dead from 
colorectal cancer at 80 (not 
recommended in average risk 
patients except in research 
programs)
Not acceptable Over-estimation of familial risk. 
Over estimation of the benefit/risk 
of colonoscopy
More explanation and information 
on evidence
Cervical cancer screening in a 55-
year old women (pap smear 
recommended until 70 years of 
age)
Acceptable - -
Prostate cancer mass screening in 
men aged more than 50 (screening 
not recommended)
Intermediate Poor knowledge of evidence More information on evidence
# Acceptance: "not acceptable"= no concordance with the recommendation of EsPeR and negative comments from physicians; "intermediate" = no 
concordance but no negative comments or concordance but negative comments; "acceptable" = concordance with the recommendation of EsPeR 
and positive commentsBMC Medical Informatics and Decision Making 2003, 3 http://www.biomedcentral.com/1472-6947/3/13
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integrate them in EsPeR. We also experienced difficulties
in implementing the French guidelines on cardiovascular
prevention because of the heterogeneity of recommended
tools for risk stratification.
We ran a pilot qualitative study in laboratory, in order to
observe physicians' reaction and behaviour while using
EsPeR  and to find with them some explanations. We
interpreted the collected verbatim and observations as
potential barriers and facilitators for the diffusion of this
tool. No focus group session was recorded or videotaped
and no social scientist was involved in the study: the
groups were animated by three different investigators
among whom one was not involved directly in the design
of EsPeR and supposed to be "neutral". Recruitment was
different for both sessions (in January and October) and
led to very different groups which interestingly suggested
that different kinds of reactions may pertain to different
backgrounds (socio-professional environment, use of
informatics, etc.).
Despite these limitations, ergonomics problems were eas-
ily identified thanks to the first two focus groups. Correc-
tive measures were taken in the version 2 and led to solve
these problems, as verified with the second session of
focus groups. The main problems pertained to the content
of EsPeR and presentation of knowledge. Analysis of these
results led to several actions. The first one consisted in giv-
ing a feedback to the ANAES (the French national agency
in charge of the development of guidelines) on difficulties
encountered while computerizing guidelines. This
resulted in a partnership between our laboratory and the
ANAES to set up a guideline development framework
designed for the guideline authors, in order for them to
write directly and unequivocally "computerizable" guide-
lines. Our results also suggest that improving the quality
of preventive strategies in the primary care setting requires
considering the multiple competing demands faced by
patients and physicians during each consultation. The
promotion of the EsPeR  system, designed for assisting
physicians in setting rational priorities in prevention strat-
egies, should therefore include both an educational inter-
vention (i.e. teaching evidence and the concept of risk for
increasing physician's confidence in recommendations)
and an organisational intervention (i.e. increase of the
consultation duration to allow the complete use of the
computerised decision support system, or promote the
delegation of certain tasks to nurse practitioners).
The key assumption made by people developing decision
aids is that providing decision support (recommenda-
tions, alerts, reminders, calculations) as well as useful
clinical information at the point of care can reduce unwar-
ranted variations in care and improve patients' health. It
is generally acknowledged that computerised reminders
and alerts improve the practice of simple preventive meas-
ures (screening, vaccinations...) [16]. However, more
complex decision support systems such as computerised
guidelines [17], or calculation of cardiovascular risk [18]
did not improved quality of care in several recent well
designed randomised trials. These findings can have sev-
eral explanations: either the system does not work, or it is
not used because it does not fit the physicians' needs or
else it is in conflict with physicians beliefs and constraints.
In keeping with this idea, some authors encourage evalu-
ating computerised decision support systems not only
with randomised trials [19]. In some examples, a qualita-
tive study helps to explain the negative of poor results of
a randomised controlled trial [17,20]. We therefore plan a
qualitative on-field evaluation of the system to assess its
usability and its acceptance by general practitioners on
larger scale, in two different regions of France, before con-
sidering evaluating its impact in a randomised trial.
Conclusion
We presented an original computerized decision support
system for medical prevention based on concepts like
risks and complex knowledge found in clinical practice
guidelines. The pilot qualitative evaluation of this system
reinforces the need of training on its content, prior to its
on-field evaluation. The main perspective of this work is
the design of a larger qualitative study to evaluate the uti-
lization and barriers to acceptance of the EsPeR system in
the day to day practice. Potential important implication of
this project could be the use of EsPeR as a structuring tool
for prevention strategies in ambulatory medicine.
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